文献速递冠心病血脂与心血管预防

肝移植受者冠状动脉粥样硬化患病率与严重程度:基于方案化CT血管造影的全国性研究

Coronary Atherosclerosis in Liver Transplant Recipients and Population Controls: A Nationwide Study Using Protocolized CT Angiography.
PubMed 文献 · J Am Coll Cardiol · 2026-03-04

该横断面研究将205例≥40岁肝移植受者按年龄和性别1:5匹配1025例人群对照,统一进行冠状动脉CT血管造影。肝移植受者任何冠状动脉粥样硬化(63% vs 46%)、阻塞性(18% vs 10%)及阻塞性广泛性(13% vs 6%)患病率均显著更高,校正传统危险因素后仍与更高风险相关。

要点

  • 肝移植受者冠状动脉粥样硬化患病率和严重程度显著高于匹配人群对照。
  • 校正年龄、性别、高血压、糖尿病、血脂异常、吸烟和肥胖后,肝移植仍与更高冠脉粥样硬化风险相关。
  • 建议对肝移植受者进行有意识的心血管风险评估和预防策略。

核心结论

  • 肝移植受者冠状动脉粥样硬化的患病率和严重程度显著高于年龄性别匹配的一般人群对照,且在校正传统心血管危险因素后仍存在关联。

研究设计与样本

  • 横断面研究,纳入DACOLT研究中≥40岁肝移植受者205例,按年龄和性别1:5匹配Copenhagen General Population Study人群对照1025例。
  • 所有参与者统一完成问卷、体格检查和冠状动脉CT血管造影。
  • 冠脉粥样硬化分类为任何、阻塞性(≥50%狭窄)和广泛性(>5个冠脉节段)冠状动脉粥样硬化。
  • 采用逻辑回归校正年龄、性别、高血压、糖尿病、血脂异常、吸烟和肥胖。

主要发现

  • 肝移植受者与对照的SCORE2风险无显著差异(P=0.20)。
  • 肝移植受者任何冠状动脉粥样硬化患病率63% vs 对照46%(P<0.0001)。
  • 肝移植受者阻塞性冠状动脉粥样硬化患病率18% vs 对照10%(P<0.0001)。
  • 肝移植受者阻塞性广泛性冠状动脉粥样硬化患病率13% vs 对照6%(P<0.0001)。
  • 校正混杂因素后,肝移植与任何冠状动脉粥样硬化(OR 2.19;95%CI 1.48-3.27)、阻塞性(OR 2.73;95%CI 1.43-5.16)和阻塞性广泛性(OR 3.90;95%CI 1.76-8.55)的更高风险相关。

临床怎么用

  • 对肝移植受者应考虑进行有意识的心血管风险评估和预防策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Prevalence and severity of coronary atherosclerosis in liver transplant (LTx) recipients remain poorly characterized because prior work has relied on clinically indicated imaging or retrospective studies. OBJECTIVES: The purpose of this study was to determine the prevalence and severity of coronary atherosclerosis in LTx recipients compared with control subjects using protocolized research-coronary CT angiography in both LTx recipients and control subjects. METHODS: In this cross-sectional study, LTx recipients aged ≥40 years from the DACOLT (Danish Comorbidity in Liver Transplant Recipients) study were matched 1:5 by age and sex with population controls from the Copenhagen General Population Study. Questionnaires, physical examinations, and coronary computed tomography angiography were performed uniformly in all participants. Coronary atherosclerosis was categorized as any, obstructive (≥50% stenosis), and extensive (>5 coronary segments) coronary atherosclerosis. Logistic regressions were adjusted for age, sex, hypertension, diabetes, dyslipidemia, smoking, and obesity. RESULTS: We included 205 LTx recipients and 1,025 population control subjects. Median age was 56 years, and 40% were women. SCORE2 (Systematic COronary Risk Evaluation 2) risk did not differ significantly between LTx recipients and control subjects (P = 0.20). LTx recipients had significantly higher prevalence of any coronary atherosclerosis (63% vs 46%; P < 0.0001), obstructive coronary atherosclerosis (18% vs 10%; P < 0.0001), and obstructive-extensive coronary atherosclerosis (13% vs 6%; P < 0.0001), than control subjects. After adjusting for confounders, living with a transplanted liver remained associated with higher odds of any coronary atherosclerosis (OR: 2.19; 95% CI: 1.48-3.27), obstructive coronary atherosclerosis (OR: 2.73; 95% CI: 1.43-5.16), and obstructive-extensive coronary atherosclerosis (OR: 3.90; 95% CI: 1.76-8.55). Among individuals with any coronary atherosclerosis, LTx recipients had higher odds of having high-risk plaque than population control subjects (OR: 2.10; 95% CI: 1.29-3.45). CONCLUSIONS: LTx recipients had a significantly higher prevalence and severity of coronary atherosclerosis compared with matched general population control subjects, after adjusting for traditional cardiovascular risk factors. Conscious cardiovascular risk assessment and preventive strategies should be considered in this patient group. (The Danish Comorbidity in Liver Transplant Recipients Study [DACOLT]; NCT04777032).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Knudsen AD, Kühl JT, Schultz NA, et al. Coronary Atherosclerosis in Liver Transplant Recipients and Population Controls: A Nationwide Study Using Protocolized CT Angiography. J Am Coll Cardiol. 2026. PMID: 41778959. doi:10.1016/j.jacc.2026.01.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。